SI2865422T1 - Alfa-MSH derivati za zdravljenje fotodermatoz - Google Patents

Alfa-MSH derivati za zdravljenje fotodermatoz

Info

Publication number: SI2865422T1
Authority: SI; Slovenia
Prior art keywords: photodermatoses; alpha; treatment; msh derivatives; msh
Prior art date: 2006-08-31

Application number

SI200731978T

Other languages

English (en)

Inventor

Philippe Wolgen

Original Assignee

Clinuvel Pharmaceuticals Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-08-31

Filing date

2007-08-31

Publication date

2017-12-29

2006-08-31 Priority claimed from AU2006904745A external-priority patent/AU2006904745A0/en

2007-08-31 Application filed by Clinuvel Pharmaceuticals Limited filed Critical Clinuvel Pharmaceuticals Limited

2017-12-29 Publication of SI2865422T1 publication Critical patent/SI2865422T1/sl

Links

206010041303 Solar dermatitis Diseases 0.000 title 1
WHNFPRLDDSXQCL-UAZQEYIDSA-N α-msh Chemical class C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)NC(=O)[C@H](CO)NC(C)=O)C1=CC=C(O)C=C1 WHNFPRLDDSXQCL-UAZQEYIDSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- A61K38/34—Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Zoology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Birds (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Endocrinology (AREA)
Chemical Kinetics & Catalysis (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Toxicology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

SI200731978T 2006-08-31 2007-08-31 Alfa-MSH derivati za zdravljenje fotodermatoz SI2865422T1 (sl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
AU2006904745A AU2006904745A0 (en)		2006-08-31	Method for Treatment of Photodermatoses
AU2007900862A AU2007900862A0 (en)		2007-02-21	Method for treatment of photodermatoses
EP14173509.2A EP2865422B1 (en)	2006-08-31	2007-08-31	Alpha-MSH derivatives for the treatment of photodermatoses

Publications (1)

Publication Number	Publication Date
SI2865422T1 true SI2865422T1 (sl)	2017-12-29

Family

ID=39135428

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SI200731566T SI2056855T1 (sl)	2006-08-31	2007-08-31	Alfa-msh derivati za zdravljenje fotodermazoze
SI200731978T SI2865422T1 (sl)	2006-08-31	2007-08-31	Alfa-MSH derivati za zdravljenje fotodermatoz

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
SI200731566T SI2056855T1 (sl)	2006-08-31	2007-08-31	Alfa-msh derivati za zdravljenje fotodermazoze

Country Status (16)

Country	Link
US (1)	US8334265B2 (sl)
EP (2)	EP2056855B1 (sl)
AU (1)	AU2007291886B2 (sl)
CA (1)	CA2662163C (sl)
CY (1)	CY1115804T1 (sl)
DK (2)	DK2056855T3 (sl)
ES (2)	ES2646049T3 (sl)
HU (2)	HUE035074T2 (sl)
LU (1)	LUC00062I2 (sl)
NL (1)	NL300926I2 (sl)
NZ (1)	NZ575133A (sl)
PL (2)	PL2056855T3 (sl)
PT (2)	PT2056855E (sl)
SI (2)	SI2056855T1 (sl)
WO (1)	WO2008025094A1 (sl)
ZA (1)	ZA200901364B (sl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA200901365B (en) *	2006-08-28	2010-05-26	Clinuvel Pharmaceuticals Ltd	Method for reducing incidence or rate of development of skin cancers and related conditions
EP2259794A1 (en) *	2008-02-22	2010-12-15	Clinuvel Pharmaceuticals Limited	Method for treatment of photosensitivity and phototoxicity
NZ588213A (en)	2008-03-27	2012-10-26	Clinuvel Pharmaceuticals Ltd	Alpha-msh analogues for treating or preventing vitiligo
EP2440572B1 (en)	2009-06-08	2017-04-05	Palatin Technologies, Inc.	Lactam-bridged melanocortin receptor-specific peptides
NZ596617A (en)	2009-06-08	2014-04-30	Palatin Technologies Inc	Melanocortin receptor-specific peptides
US8979797B2 (en) *	2010-12-16	2015-03-17	Ams Research Corporation	High pressure delivery system and method for treating pelvic disorder using large molecule therapeutics
EP2487185A1 (en) *	2011-02-11	2012-08-15	Clinuvel Pharmaceuticals Limited	Hexapeptide with improved activity in the repair of cellular DNA of dermal cells
US9371555B2 (en)	2012-06-01	2016-06-21	Concordia Laboratories Inc.	Lighting systems and methods of using lighting systems for in vitro potency assay for photofrin
US9637744B2 (en)	2013-06-13	2017-05-02	Inserm (Institut National De La Sante Et De La Recherche Medicale)	Methods and pharmaceutical compositions for the treatment of erythropoietic protoporphyria
WO2015063099A1 (en) *	2013-10-28	2015-05-07	Clinuvel Ag	Alpha-msh analogues for use in the treatment of hailey-hailey disease
WO2015063102A1 (en) *	2013-10-28	2015-05-07	Clinuvel Ag	Alpha-msh analogues for use in bullous disease
EP3088417A1 (en)	2015-04-28	2016-11-02	Vallaurix Pte. Ltd.	Pharmaceutical compound
EP3088418A1 (en)	2015-04-28	2016-11-02	Vallaurix Pte. Ltd.	Pharmaceutical compound
EP3573645B1 (en) *	2017-02-01	2024-03-13	Vallaurix Mc S.A.R.L.	Alpha-msh analogues used in the treatment of xeroderma pigmentosum
KR20230016006A (ko)	2020-06-10	2023-01-31	미쓰비시 타나베 파마 코퍼레이션	포르피린증의 예방 또는 치료제
WO2021251450A1 (ja)	2020-06-10	2021-12-16	田辺三菱製薬株式会社	ポルフィリン症の予防又は治療剤
KR20230016008A (ko)	2020-06-10	2023-01-31	미쓰비시 타나베 파마 코퍼레이션	광선성 피부질환의 예방 또는 치료제

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4457864A (en)	1981-10-23	1984-07-03	University Patents, Inc.	Synthetic analogues of α-melanotropin
US4485039A (en)	1982-06-11	1984-11-27	University Patents, Inc.	Synthetic analogues of α-melanotropin
ATE84420T1 (de)	1986-02-03	1993-01-15	University Patents Inc	Verfahren zur stimulierung von melanozyten durch lokales anbringen von alpha-msh-analogen, sowie zusammensetzungen.
US5674839A (en)	1987-05-22	1997-10-07	Competitive Technologies, Inc.	Cyclic analogs of alpha-MSH fragments
US5049547A (en)	1988-02-11	1991-09-17	University Patents, Inc.	Composition for stimulating integumental melanocytes
US5252318A (en)	1990-06-15	1993-10-12	Allergan, Inc.	Reversible gelation compositions and methods of use
WO1998000166A1 (en)	1996-07-03	1998-01-08	Merial, Inc.	Recombinant canine adenovirus (cav) containing exogenous dna
US5990091A (en)	1997-03-12	1999-11-23	Virogenetics Corporation	Vectors having enhanced expression, and methods of making and uses thereof
ATE350486T1 (de)	1998-05-15	2007-01-15	Quark Biotech Inc	Durch mechanischen stress induzierte gene, deren expressionsprodukte und deren verwendung.
NZ534450A (en) *	2002-02-26	2008-08-29	Arizona Board Of Regents Of Be	Method of stimulation of melanin production and induction of skin tanning comprising administering alpha-MSH and exposing skin to UV irradiation
ES2566801T3 (es)	2004-08-04	2016-04-15	Clinuvel Pharmaceuticals Limited	Métodos de inducción de melanogénesis en un sujeto
WO2006037188A1 (en)	2004-10-08	2006-04-13	Clinuvel Pharmaceuticals Limited	Compositions and methods for inducing melanogenesis in a subject
ZA200901365B (en) *	2006-08-28	2010-05-26	Clinuvel Pharmaceuticals Ltd	Method for reducing incidence or rate of development of skin cancers and related conditions

2007
- 2007-08-31 SI SI200731566T patent/SI2056855T1/sl unknown
- 2007-08-31 PT PT78002342T patent/PT2056855E/pt unknown
- 2007-08-31 WO PCT/AU2007/001276 patent/WO2008025094A1/en not_active Ceased
- 2007-08-31 PL PL07800234T patent/PL2056855T3/pl unknown
- 2007-08-31 EP EP07800234.2A patent/EP2056855B1/en active Active
- 2007-08-31 DK DK07800234.2T patent/DK2056855T3/en active
- 2007-08-31 AU AU2007291886A patent/AU2007291886B2/en active Active
- 2007-08-31 HU HUE14173509A patent/HUE035074T2/en unknown
- 2007-08-31 EP EP14173509.2A patent/EP2865422B1/en active Active
- 2007-08-31 ES ES14173509.2T patent/ES2646049T3/es active Active
- 2007-08-31 SI SI200731978T patent/SI2865422T1/sl unknown
- 2007-08-31 PL PL14173509T patent/PL2865422T3/pl unknown
- 2007-08-31 PT PT141735092T patent/PT2865422T/pt unknown
- 2007-08-31 ES ES07800234.2T patent/ES2525476T3/es active Active
- 2007-08-31 DK DK14173509.2T patent/DK2865422T3/da active
- 2007-08-31 US US12/438,990 patent/US8334265B2/en active Active
- 2007-08-31 CA CA2662163A patent/CA2662163C/en active Active
- 2007-08-31 ZA ZA200901364A patent/ZA200901364B/xx unknown
- 2007-08-31 NZ NZ575133A patent/NZ575133A/en not_active IP Right Cessation
2014
- 2014-12-08 CY CY20141101016T patent/CY1115804T1/el unknown
2018
- 2018-01-31 NL NL300926C patent/NL300926I2/nl unknown
- 2018-02-02 LU LU00062C patent/LUC00062I2/fr unknown
- 2018-02-12 HU HUS1800006C patent/HUS1800006I1/hu unknown

Also Published As

Publication number	Publication date
DK2056855T3 (en)	2014-12-15
CA2662163A1 (en)	2008-03-06
NL300926I2 (nl)	2018-03-20
LUC00062I1 (sl)	2018-02-08
HUS1800006I1 (hu)	2018-05-02
DK2865422T3 (da)	2017-11-20
EP2056855B1 (en)	2014-09-17
ES2525476T3 (es)	2014-12-23
PT2056855E (pt)	2014-12-12
HK1130208A1 (en)	2009-12-24
SI2056855T1 (sl)	2015-01-30
AU2007291886B2 (en)	2013-01-10
LUC00062I2 (sl)	2018-03-28
WO2008025094A1 (en)	2008-03-06
HUE035074T2 (en)	2018-05-02
US8334265B2 (en)	2012-12-18
CA2662163C (en)	2015-11-24
EP2865422B1 (en)	2017-10-18
PT2865422T (pt)	2017-11-14
AU2007291886A1 (en)	2008-03-06
ES2646049T3 (es)	2017-12-11
PL2056855T3 (pl)	2015-04-30
EP2056855A1 (en)	2009-05-13
EP2056855A4 (en)	2013-06-19
US20100120668A1 (en)	2010-05-13
CY1115804T1 (el)	2017-01-25
PL2865422T3 (pl)	2018-01-31
ZA200901364B (en)	2010-06-30
EP2865422A1 (en)	2015-04-29
NZ575133A (en)	2011-11-25

Publication	Publication Date	Title
HUS1800006I1 (hu)	2018-05-02	Alfa-MSH származékok fotodermatózisok kezelésére
ZA200805877B (en)	2009-07-29	Pyridiazinone derivatives for tumour treatment
IL198847A (en)	2015-07-30	Process for making 2-imino-thiazolidine-4-on and several such histories
IL197137A0 (en)	2009-11-18	Tonsillitis treatment
IL192690A0 (en)	2009-02-11	Hydantoin derivatives for the treatment of inflammatory disorders
ZA201001264B (en)	2011-07-27	1-amino-alkylcycohxane derivatives for the treatment of cochleat tinnitus
IL196202A0 (en)	2009-09-22	Indazole derivatives for the treatment of hsp90-induced diseases
ZA200805159B (en)	2009-03-25	Imidazole derivatives for the treatment of gastrointestinal disorders
ZA201007362B (en)	2012-05-30	Conjugates for the treatment of mesothelioma
IL192933A0 (en)	2009-02-11	Benzoisoindole derivatives for the treatment of pain
ZA200904328B (en)	2010-09-29	Prophylactic or therapeutic agent for alopecia
IL226363A0 (en)	2013-06-27	Compounds and methods for treating cancer
PL380561A1 (pl)	2008-03-17	Sposób otrzymywania pochodnych antracyklin
ZA200800921B (en)	2009-06-24	Pyrazolone derivatives for the treatment of tuberculosis
IL194737A0 (en)	2009-08-03	2-alkenyl-3-aminothiophene derivatives and processes for the preparation thereof
GB0624439D0 (en)	2007-01-17	Technique for treatment of gall-and kidney-stones
GB0602857D0 (en)	2006-03-22	The treatment of sialorrhoea
ZA200806180B (en)	2009-07-29	Benzoisoindole derivatives for the treatment of pain
GB0604114D0 (en)	2006-04-12	Combinations for the treatment of cancer
GB0602855D0 (en)	2006-03-22	The Treatment Of Sialorrhoea
GB0602858D0 (en)	2006-03-22	The treatment of sialorrhoea
ZA200707384B (en)	2008-11-26	Process for the preparation of 1-aminopiperidine derivatives
IL194261A0 (en)	2009-09-22	S-alkylisothiouronium derivatives for the treatment of inflammatory diseases
HK1122032A (en)	2009-05-08	Benzoisoindole derivatives for the treatment of pain
GB0715257D0 (en)	2007-09-12	Phenylthiazolylpiperazine derivatives for the treatment of nuero degenerative diseases